Pathophysiology, research challenges, and clinical management of smoke inhalation injury

Perenlei Enkhbaatar, Basil A. Pruitt, Oscar Suman, Ronald Mlcak, Steven Wolf, Hiroyuki Sakurai, David Herndon

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Smoke inhalation injury is a serious medical problem that increases morbidity and mortality after severe burns. However, relatively little attention has been paid to this devastating condition, and the bulk of research is limited to preclinical basic science studies. Moreover, no worldwide consensus criteria exist for its diagnosis, severity grading, and prognosis. Therapeutic approaches are highly variable depending on the country and burn centre or hospital. In this Series paper, we discuss understanding of the pathophysiology of smoke inhalation injury, the best evidence-based treatments, and challenges and future directions in diagnostics and management.

Original languageEnglish (US)
Pages (from-to)1437-1446
Number of pages10
JournalThe Lancet
Volume388
Issue number10052
DOIs
StatePublished - Oct 1 2016

Fingerprint

Smoke Inhalation Injury
Burn Units
Burns
Research
Morbidity
Mortality
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pathophysiology, research challenges, and clinical management of smoke inhalation injury. / Enkhbaatar, Perenlei; Pruitt, Basil A.; Suman, Oscar; Mlcak, Ronald; Wolf, Steven; Sakurai, Hiroyuki; Herndon, David.

In: The Lancet, Vol. 388, No. 10052, 01.10.2016, p. 1437-1446.

Research output: Contribution to journalReview article

Enkhbaatar, Perenlei ; Pruitt, Basil A. ; Suman, Oscar ; Mlcak, Ronald ; Wolf, Steven ; Sakurai, Hiroyuki ; Herndon, David. / Pathophysiology, research challenges, and clinical management of smoke inhalation injury. In: The Lancet. 2016 ; Vol. 388, No. 10052. pp. 1437-1446.
@article{b44a3126bca04785ad22ebe50a11fd5f,
title = "Pathophysiology, research challenges, and clinical management of smoke inhalation injury",
abstract = "Smoke inhalation injury is a serious medical problem that increases morbidity and mortality after severe burns. However, relatively little attention has been paid to this devastating condition, and the bulk of research is limited to preclinical basic science studies. Moreover, no worldwide consensus criteria exist for its diagnosis, severity grading, and prognosis. Therapeutic approaches are highly variable depending on the country and burn centre or hospital. In this Series paper, we discuss understanding of the pathophysiology of smoke inhalation injury, the best evidence-based treatments, and challenges and future directions in diagnostics and management.",
author = "Perenlei Enkhbaatar and Pruitt, {Basil A.} and Oscar Suman and Ronald Mlcak and Steven Wolf and Hiroyuki Sakurai and David Herndon",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/S0140-6736(16)31458-1",
language = "English (US)",
volume = "388",
pages = "1437--1446",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "10052",

}

TY - JOUR

T1 - Pathophysiology, research challenges, and clinical management of smoke inhalation injury

AU - Enkhbaatar, Perenlei

AU - Pruitt, Basil A.

AU - Suman, Oscar

AU - Mlcak, Ronald

AU - Wolf, Steven

AU - Sakurai, Hiroyuki

AU - Herndon, David

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Smoke inhalation injury is a serious medical problem that increases morbidity and mortality after severe burns. However, relatively little attention has been paid to this devastating condition, and the bulk of research is limited to preclinical basic science studies. Moreover, no worldwide consensus criteria exist for its diagnosis, severity grading, and prognosis. Therapeutic approaches are highly variable depending on the country and burn centre or hospital. In this Series paper, we discuss understanding of the pathophysiology of smoke inhalation injury, the best evidence-based treatments, and challenges and future directions in diagnostics and management.

AB - Smoke inhalation injury is a serious medical problem that increases morbidity and mortality after severe burns. However, relatively little attention has been paid to this devastating condition, and the bulk of research is limited to preclinical basic science studies. Moreover, no worldwide consensus criteria exist for its diagnosis, severity grading, and prognosis. Therapeutic approaches are highly variable depending on the country and burn centre or hospital. In this Series paper, we discuss understanding of the pathophysiology of smoke inhalation injury, the best evidence-based treatments, and challenges and future directions in diagnostics and management.

UR - http://www.scopus.com/inward/record.url?scp=84994881892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994881892&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(16)31458-1

DO - 10.1016/S0140-6736(16)31458-1

M3 - Review article

C2 - 27707500

AN - SCOPUS:84994881892

VL - 388

SP - 1437

EP - 1446

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 10052

ER -